Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Liraglutide in Newly Onset Type 1 Diabetes. (NewLira)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01879917
Recruitment Status : Active, not recruiting
First Posted : June 18, 2013
Last Update Posted : December 12, 2018
Sponsor:
Collaborators:
Steno Diabetes Center Copenhagen
Hillerod Hospital, Denmark
Bispebjerg Hospital
Odense University Hospital
Aarhus University Hospital
Aalborg University Hospital
Hospital of South West Denmark
Information provided by (Responsible Party):
Thomas Dejgaard, Hvidovre University Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : November 2018
Estimated Study Completion Date : December 2018